Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.0%

2 terminated out of 25 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

20%

5 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results82% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (10)
P 1 (3)
P 2 (2)
P 3 (3)
P 4 (2)

Trial Status

Completed9
Recruiting5
Unknown3
Active Not Recruiting3
Terminated2
Enrolling By Invitation2

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT06085664Phase 1Recruiting

A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

NCT06873581Phase 3RecruitingPrimary

Pivotal Study of Voro Urologic Scaffold

NCT04687969Active Not Recruiting

Multimodal Machine Learning Characterization of Solid Tumors

NCT07516886Recruiting

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

NCT05553327Not ApplicableCompleted

Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

NCT07426861Not ApplicableRecruiting

Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence

NCT07333807Not ApplicableCompleted

Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy

NCT06803602Not ApplicableEnrolling By Invitation

HIFEM Technology for Post-Radical Prostatectomy and Post-Holmium Laser Prostate Surgery

NCT06351579Completed

Data Collection Post Radical Prostatectomy

NCT04067570Not ApplicableActive Not Recruiting

Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer

NCT05332340Phase 1Completed

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

NCT06275945Phase 2Active Not Recruiting

Feasibility Study of A VoRo UrologIc ScaffolD (ARID)

NCT05558007Phase 2Recruiting

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

NCT00953277Phase 4Completed

Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer

NCT04399876Phase 1Enrolling By Invitation

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

NCT03338712Withdrawn

Micro-RNA Expression Profiles in Localised Prostate Cancer

NCT04862533Not ApplicableCompleted

Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA)

NCT05625048Not ApplicableUnknown

Urinary Incontinence After Radical Prostatectomy

NCT03639389Phase 3CompletedPrimary

Postoperative Pain, Recovery and Discharge Following Robot-assisted Laparoscopic Prostatectomy

NCT00955929Not ApplicableTerminated

Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy

Scroll to load more

Research Network

Activity Timeline